Research Articles
Hope for Refractory Rheumatoid Arthritis: How Filgotinib Is Changing Treatment in Japan
Explore how filgotinib, a selective JAK inhibitor, offers new hope for Japanese patients with refractory rheumatoid arthritis who haven't responded to biologic DMARDs.
Beyond Joints: How Filgotinib Brings Relief from Rheumatoid Arthritis's Hidden Burdens
Discover how filgotinib provides rapid relief from pain and fatigue while improving quality of life for rheumatoid arthritis patients with inadequate response to biologic DMARDs.